Massachusetts General Hospital: Carcinoma trials

The registry lists 23 Carcinoma studies with Massachusetts General Hospital as lead sponsor. 1 are open to participants now and 7 have results posted.

Early Phase 1 2Phase 1 4Phase 2 12No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TCRecruitingNCT05668962Phase 2
• Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung CancerCompletedNCT02394548Not applicableResults posted
• Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436CompletedNCT01534897Not applicableResults posted
• Correlation Between Skin Carotenoid Levels and Previous History of Skin CancerCompletedNCT00836342Results posted
• Proton Radiotherapy With Chemotherapy for Nasopharyngeal CarcinomaCompletedNCT00592501Phase 2Results posted
• Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell CarcinomaCompletedNCT00556049Phase 2Results posted
• RAD001 in Advanced Hepatocellular CarcinomaCompletedNCT00516165Phase 1/2Results posted
• Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00392665Phase 2Results posted
• PET/MRI in Endometrial CancerWithdrawnNCT05390021Not applicable
• Optical Imaging for Preoperative Delineation of Nonmelanoma Skin CancersStatus unknownNCT02666833
• 24hr Imaging Of HCC After EOVISTWithdrawnNCT01968629Early Phase 1
• A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine GreenCompletedNCT01962649Early Phase 1
• STA-9090 in Patients With Advanced Hepatocellular CancerCompletedNCT01665937Phase 1
• Intensity-Modulated or Proton Radiation Therapy for Sinonasal MalignancyActive, not recruitingNCT01586767Not applicable
• Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian OriginStatus unknownNCT00652119Phase 1
• Photochemical Tissue BondingCompletedNCT00586040Phase 2
• Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell CarcinomaWithdrawnNCT00556205Phase 2
• Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and NeckCompletedNCT00513383Phase 1
• SU011248 in Advanced Hepatocellular CarcinomaCompletedNCT00361309Phase 2
• Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian OriginCompletedNCT00181701Phase 2
• Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian CancerCompletedNCT00181688Phase 2
• Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular CarcinomaCompletedNCT00142467Phase 2
• Cetuximab in Patients With Unresectable or Metastatic Hepatocellular CarcinomaCompletedNCT00142428Phase 2